Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolford

Showing results (691-700 of 709) with videos related to

Pageof 71
Sort By:
Cell Genomics|February 13, 2023
The HUNT study: A population-based cohort for genetic researchBen M Brumpton, Sarah Graham, Ida Surakka, et al.
Human Molecular Genetics|May 7, 2021
Genome-wide association study of cardiac troponin I in the general populationMarta R Moksnes, Helge Røsjø, Anne Richmond, et al.
Journal of Medicinal Chemistry|October 29, 2015
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular DiseasesRoger B Ruggeri, Leonard Buckbinder, Scott W Bagley, et al.
Journal of Medicinal Chemistry|August 5, 2016
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic NephropathyKimberly O Cameron, Daniel W Kung, Amit S Kalgutkar, et al.
Nature Communications|June 30, 2016
The genetic regulatory signature of type 2 diabetes in human skeletal muscleLaura J Scott, Michael R Erdos, Jeroen R Huyghe, et al.
Diabetes|September 28, 2006
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studiesCornelia Huth, Iris M Heid, Caren Vollmert, et al.
American Journal of Human Genetics|July 15, 2021
Regulatory variants in TCF7L2 are associated with thoracic aortic aneurysmTanmoy Roychowdhury, Haocheng Lu, Whitney E Hornsby, et al.
Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.
American Journal of Human Genetics|January 2, 2018
Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac DevelopmentJonas B Nielsen, Lars G Fritsche, Wei Zhou, et al.
Nature Genetics|August 1, 2018
Biobank-driven genomic discovery yields new insight into atrial fibrillation biologyJonas B Nielsen, Rosa B Thorolfsdottir, Lars G Fritsche, et al.
Pageof 71

Showing results (691-700 of 709) with videos related to

Sort By:
Pageof 71
Cell Genomics|February 13, 2023
The HUNT study: A population-based cohort for genetic researchBen M Brumpton, Sarah Graham, Ida Surakka, et al.
Human Molecular Genetics|May 7, 2021
Genome-wide association study of cardiac troponin I in the general populationMarta R Moksnes, Helge Røsjø, Anne Richmond, et al.
Journal of Medicinal Chemistry|October 29, 2015
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular DiseasesRoger B Ruggeri, Leonard Buckbinder, Scott W Bagley, et al.
Journal of Medicinal Chemistry|August 5, 2016
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic NephropathyKimberly O Cameron, Daniel W Kung, Amit S Kalgutkar, et al.
Nature Communications|June 30, 2016
The genetic regulatory signature of type 2 diabetes in human skeletal muscleLaura J Scott, Michael R Erdos, Jeroen R Huyghe, et al.
Diabetes|September 28, 2006
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studiesCornelia Huth, Iris M Heid, Caren Vollmert, et al.
American Journal of Human Genetics|July 15, 2021
Regulatory variants in TCF7L2 are associated with thoracic aortic aneurysmTanmoy Roychowdhury, Haocheng Lu, Whitney E Hornsby, et al.
Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.
American Journal of Human Genetics|January 2, 2018
Genome-wide Study of Atrial Fibrillation Identifies Seven Risk Loci and Highlights Biological Pathways and Regulatory Elements Involved in Cardiac DevelopmentJonas B Nielsen, Lars G Fritsche, Wei Zhou, et al.
Nature Genetics|August 1, 2018
Biobank-driven genomic discovery yields new insight into atrial fibrillation biologyJonas B Nielsen, Rosa B Thorolfsdottir, Lars G Fritsche, et al.
Pageof 71